Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHarrow Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $0.02 | $0.02 | $0.02 |
| Q2 2025 | 1 | $0.07 | $0.09 | $0.08 |
| Q3 2025 | 1 | $0.09 | $0.12 | $0.10 |
| Q4 2025 | 1 | $0.17 | $0.22 | $0.19 |
| Q1 2026 | 1 | $0.24 | $0.30 | $0.26 |
| Q2 2026 | 1 | $0.29 | $0.37 | $0.32 |
| Q3 2026 | 1 | $0.32 | $0.41 | $0.36 |
| Q4 2026 | 1 | $0.46 | $0.58 | $0.51 |
Harrow Health, Inc. Earnings Date And Information
Harrow Health, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.07. The company had revenue of 49.26 M for the quarter and had revenue of 130.19 M for the year. Harrow Health, Inc. has generated $-1 earnings per share over the last year ($-0.75 diluted earnings per share) and currently has a price-to-earnings ratio of -24.11. Harrow Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Harrow Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | N/A | -$0.12 | N/A | $52.80 M | $49.26 M |
| 08/07/2024 | Q2 2024 | -$0.25 | -$0.18 | 0.07 | $42.51 M | $48.94 M |
| 05/13/2024 | Q1 2024 | -$0.25 | -$0.38 | -0.13 | N/A | $34.59 M |
| 03/19/2024 | Q4 2023 | -$0.05 | -$0.26 | -0.21 | N/A | $36.36 M |
| 11/13/2023 | Q3 2023 | -$0.02 | -$0.13 | -0.11 | $37.58 M | $34.27 M |
| 08/09/2023 | Q2 2023 | -$0.01 | -$0.14 | -0.13 | $31.04 M | $33.47 M |
| 05/11/2023 | Q1 2023 | -$0.06 | -$0.22 | -0.16 | N/A | $26.10 M |
| 03/23/2023 | Q4 2022 | -$0.15 | $0.04 | 0.19 | N/A | $20.33 M |
| 11/14/2022 | Q3 2022 | -$0.00 | -$0.24 | -0.24 | $23.14 M | $22.82 M |
| 08/09/2022 | Q2 2022 | -$0.00 | -$0.23 | -0.23 | $22.07 M | $23.32 M |
| 05/05/2022 | Q1 2022 | $0.01 | -$0.08 | -0.1 | N/A | $22.12 M |
| 03/10/2022 | Q4 2021 | $0.08 | -$0.27 | -0.35 | N/A | $20.19 M |
| 11/09/2021 | Q3 2021 | -$0.00 | -$0.31 | -0.31 | $17.44 M | $18.71 M |
| 08/10/2021 | Q2 2021 | -$0.13 | -$0.09 | 0.04 | $15.71 M | $18.13 M |
| 05/11/2021 | Q1 2021 | $0.00 | $0.01 | 0.01 | N/A | $15.44 M |
| 03/08/2021 | Q4 2020 | $0.04 | $0.04 | 0 | N/A | $14.60 M |
| 11/09/2020 | Q3 2020 | $0.17 | $0.33 | 0.16 | $9.34 M | $14.40 M |
| 08/10/2020 | Q2 2020 | -$0.05 | -$0.01 | 0.04 | $5.70 M | $8.06 M |
| 05/11/2020 | Q1 2020 | -$0.50 | -$0.50 | 0 | N/A | $11.82 M |
| 03/13/2020 | Q4 2019 | $0.13 | $0.29 | 0.16 | N/A | $12.60 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Harrow Health, Inc. Earnings: FAQ's
Harrow Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based offlast year's report dates.
The conference call for Harrow Health, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Harrow Health, Inc.'s latest earnings report can be read online.
Harrow Health, Inc. (:HROW) has a recorded annual revenue of $130.19 M.
Harrow Health, Inc. (:HROW) has a recorded net income of $-24,411,000.Harrow Health, Inc. has generated $-0.75 earnings per share over the last four quarters.
Harrow Health, Inc. (:HROW) has a price-to-earnings ratio of -24.11 and price/earnings-to-growth ratio is -22.91.